Première fois sur le site? Créez un compte ici !

Syndicat des Biologistes du Liban

Membre de l'IFCC, de l'AFCB et de la FIFBCML

Dossier COVID-19

ملفّ الكورونا المستجدّة

Last updated on June 7th, 2021

Safety Precautions

إرشادات للوقاية المنزليّة

كيفيّة تحضير محلول التعقيم الكحولي بواسطة الكلور النقي بتركيز %5

الطريقة الصحيحة لغسل اليدين بالماء والصابون

متى يعود لبنان إلى الحياة الطبيعية؟ كيف تضع المؤسسات خطة العودة إلى العمل؟ نصائح لنجاح خطة إحتواء كورونا

الكورونا… بين التعايش والمواجهة – د. وليد عمار

إرشادات دفن الموتى

Data Collection templates

إستمارة أخذ عيّنة مسح الأنف

إستمارة فحص الدم للأجسام المضادّة

Sampling and Transportation guidelines

Preparation of VTM- طريقة تحضير الناقل الوسيط للفيروس

حول جمع عيّنات لعدوى الفيروس التاجي المستجدّ

الطريقة الصحيحة لأخذ عيّنة “مسح الأنف” لضمان جودة نتيجة الفحص المِخبري

 إرشادات أخذ العيّنة في الردهة الخارجيّة للمختبر عبر طريقة الـ Drive-Thru

إرشادات نقل العيّنة إلى المُختبر المُؤَهّل لإجراء فحص الكورونا

Protective Equipment (PPEs) in the context of COVID-19 disease

معدّات الحماية الشخصيّة المُوصى باستخدامها من قبل منظّمة الصحة العالميّة في سياق مرض الكورونا المستجدّة

القناع الطبّي والقفّازات: متى وكيف؟ فيديو يشرح طريقة استخدامِها ونزعِها والتخلّص منها

فيديوهات توجيهيّة من إعداد هيئة الصحّة العامّة البريطانيّة (Public Health England)

Laboratory Testing Options

الدكتورة ميرنا جرمانوس حدّاد : ما هي أنواع الفحوصات المِخبريّة المتوفّرة لفيروس الكورونا المستجدّة؟
ما جديد الفحوصات المخبريّة للكورونا؟ – في برنامج مشاكل وحلول – مع نقولا حنّا – تلفزيون لبنان 11/9/2020

Serology Reporting Guidelines

Unified Template for “Serology” Result Reporting

Excel
نموذج عن لوائح التبليغ عن نتائج فحوصات الـ Serology Tests (DATA REPORTING)

Useful information about Rapid Diagnostic Tests

IFCC IDSA

Antigen Tests

Unified Template for “Rapid Ag Test” Result Reporting

Excel
نموذج عن لوائح التبليغ عن نتائج فحوصات الـ Rapid Ag Tests (DATA REPORTING)

Algorithms for Ag Testing

Blood Transfusion

Program of COVID-19 Convalescent plasma collection and transfusion guidance on collection, testing, processing, storage, distribution and monitored use

V 1.1 -August 2020

By: Dr Rita Feghali
National committee of blood transfusion
Ministry of Public Health

Recommendations for Investigational COVID-19 Convalescent Plasma

Updated FDA Letter of Authorization (February 23, 2021)

Evaluation Checklist for Clinical Laboratories performing Sampling and PCR testing for COVID-19

قوائم التقييم الخاصّة بالمختبرات والمستشفيات التي تقوم بأخذ العيّنات وإجراء فحص “سلسلة التفاعل البوليميرازي” بهدف تشخيص مرض الكورونا المستجدّة

Molecular Testing Guidelines

Dos and Don’ts for molecular testing

Conseils pour les tests moléculaires

Recommended Workflow in a Molecular Laboratory

Molecular Biology Testing: From sample collection to result validation

Specimen Pooling

FDA releases

Pooled Sample Testing and Screening Testing for COVID-19 (24/8/2020)

FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing (18/7/2020)

CDC releases

Interim Guidance for Use of Pooling Procedures in SARS-CoV-2 Diagnostic, Screening, and Surveillance Testing

Validation studies

Sample pooling for SARS-COV-2 RT-PCR screening (CMI journal)

Quest SARS-CoV-2 rRT-PCR
Labcorp COVID-19 RT-PCR test

Primer Design Genesig

IVD Medical Devices for COVID-19

WHO list of available protocols
FINDDX’s page for SARS-CoV-2 diagnostic pipeline
FINDDX: SARS-COV-2 DIAGNOSTICS PERFORMANCE DATA
Plateforme COVID-19 (FRANCE)
In Vitro Diagnostics FDA EUA

Alerts

Risk of Inaccurate Results with Thermo Fisher Scientific TaqPath COVID-19 Combo Kit – Letter to Clinical Laboratory Staff and Health Care Providers – Letters to Health Care Providers (8/17/2020)

FDA statement of July 6, 2020 : False Positive Results with BD SARS-CoV-2 Reagents for the BD Max System – Letter to Clinical Laboratory Staff and Health Care Providers

WHO Scientific Brief | 24 April 2020: “Immunity passports” in the context of COVID-19

FDA statement | Update on April 7, 2020: Serologic Tests

Related Regulations

اللجنة الوزارية الإستشاريّة
قرارات و تعاميم متعلّقة بالفحوصات المخبريّة لفيروس كورونا والمختبرات المؤهّلة
صفحة وزارة الصحّة لفيروس كورونا
وحدة إدارة مخاطر الكوارث

E-Learning about COVID-19

تعلُّم عن بُعد
صفحة الندوات

Scientific publications

Cette image a un attribut alt vide ; le nom du fichier est pexels-photo-1764956.jpg

Screening

Universal Screening for SARS-CoV-2 in Women Admitted for Delivery | NEJM

Diagnosis

How to Obtain a Nasopharyngeal Swab Specimen | NEJM

Serologic Tests for SARS-CoV-2: First Steps on a Long Road

SARS-CoV-2 specific antibody responses in COVID-19 patients

Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications

Stability Issues of RT-PCR Testing of SARS-CoV-2 for Hospitalized Patients Clinically Diagnosed With COVID-19

Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay

Consensus Panel Statement on Chest Imaging for COVID-19 Patients

Antibody responses to SARS-CoV-2 in patients with COVID-19 (Nature Medicine, 29 April 2020)

Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies

Clinical Performance of Two SARS-CoV-2 Serologic Assays

Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context.

The important role of serology for COVID-19 control – The Lancet

Comparison of seven commercial RT-PCR diagnostic kits for COVID-19

Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies

Diagnostic strategies for SARS-CoV-2 infection and interpretation of
microbiological results

Saliva or Nasopharyngeal Swab Specimens
for Detection of SARS-CoV-2

Genetics

Phylogenetic network analysis of SARS-CoV-2 genomes

Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom

Pathophysiology

Coagulopathy Associated with COVID-19

COVID-19: consider
cytokine storm
syndromes and
immunosuppression

Preventing
COVID-19-induced
pneumonia with
anticytokine therapy

Clinical-Characteristics

Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical Outcomes of Patients with COVID-19 Pneumonia in Intensive Care in Lombardy

Gastrointestinal Aspects of COVID-19

Coagulopathie associée au COVID-19 : les
éléments essentiels pour
l’anesthésiste-réanimateur

Blood Transfusion

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia | NEJM

Useful Documents from Scientific Societies

The Lebanese Society of Infectious Diseases and Clinical Microbiology Guidelines for the Management of COVID-19
Suggested Pharmacotherapy of Confirmed Cases with COVID-19 Based on
Investigational Drugs

منظّمة الصّحّة العالميّة – الفحوص المِخبرية للكشف عن فيروس كورونا المستجدّ في الحالات البشريّة المُشتَبه بها Fact Sheets to Accompany 2019-nCoV Real-Time RT-PCR Diagnostic Panel Test Results :Fiche : Gestion des prélèvements biologiques d’un patient suspect ou confirmé de COVID-19 – Version 6
ِAdvice on the use of point-of-care immunodiagnostic tests for COVID-19

Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays
Fact Sheet for Healthcare ProvidersAvis relatif à l’interprétation de la valeur de Ct (estimation de la charge virale) obtenue en cas de RT-PCR SARS-CoV-2 positive sur les prélèvements cliniques réalisés à des fins diagnostiques ou de dépistage – Version 3
Laboratory testing strategy recommendations for COVID-19 Fact Sheet for Patients
Advice on the use of masks in the context of COVID-19 – 5 June 2020
Laboratory biosafety guidance related to coronavirus disease (COVID-19) – 13 May 2020 Priorities for testing patients
with suspected COVID-19 infection		Cahier des charges définissant les modalités d’évaluation des performances des tests sérologiques détectant les anticorps dirigés contre le SARS-CoV-2
Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19) Place des tests sérologiques dans la stratégie de prise en charge de la maladie COVID-19
Laboratory testing of human suspected cases of novel coronavirus (nCoV) infection – 10 January 2020 Use of Cloth Face Coverings to Help Slow the Spread of COVID-19 Avis favorable au prélèvement oropharyngé en cas de contre-indication au nasopharyngé
Laboratory testing of 2019 novel coronavirus (‎‎‎‎‎‎‎‎‎‎‎‎2019-nCoV)‎‎‎‎‎‎‎‎‎‎‎‎ in suspected human cases – 17 January 2020 Implementing Safety Practices for Critical Infrastructure Workers Who May Have Had Exposure to a Person with Suspected or Confirmed COVID-19Les tests antigéniques sont performants chez les patients symptomatiques
Rational use of personal protective equipment (PPE)
for coronavirus disease (COVID-19) 		Interim Guidelines for COVID-19 Antibody Testing Revue rapide sur les tests de détection antigénique du virus SARS-CoV-2
Dépistage en laboratoire des cas suspects d’infection humaine par le nouveau coronavirus 2019
Interim Guidance for Use of Pooling Procedures in SARS-CoV-2 Diagnostic, Screening, and Surveillance Testing Évaluation de la performance diagnostique de 9 tests rapides antigéniques (TRA) COVID-19
Formulations des Produits hydro-alcooliques
Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19: a module from the suite of health service capacity assessments in the context of the COVID-19 pandemic: interim guidance, 20 November 2020

fr_FRFR
en_USENG fr_FRFR